New Antifungal Agents with Azole Moieties

Fungal conditions affect a multitude of people worldwide, leading to increased hospitalization and mortality rates, and the need for novel antifungals is emerging with the rise of resistance and immunocompromised patients. Continuous use of azole drugs, which act by inhibiting the fungal CYP51, invo...

Descripción completa

Detalles Bibliográficos
Autores principales: Teixeira, Melissa Martins, Carvalho, Diogo Teixeira, Sousa, Emília, Pinto, Eugénia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698508/
https://www.ncbi.nlm.nih.gov/pubmed/36422557
http://dx.doi.org/10.3390/ph15111427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698508/
https://www.ncbi.nlm.nih.gov/pubmed/36422557
http://dx.doi.org/10.3390/ph15111427

Ejemplares similares